Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$26.8M Sell
577,979
-171,149
-23% -$7.86M 0.27% 109
2014
Q4
$33.7M Buy
749,128
+238,704
+47% +$10.4M 0.36% 86
2014
Q3
$21.2M Sell
510,424
-115,823
-18% -$4.9M 0.3% 100
2014
Q2
$25.6M Sell
626,247
-100,417
-14% -$3.94M 0.36% 90
2014
Q1
$28M Buy
726,664
+10,599
+1% +$409K 0.41% 78
2013
Q4
$27.4M Buy
716,065
+12,328
+2% +$454K 0.47% 36
2013
Q3
$23.4M Sell
703,737
-23,520
-3% -$825K 0.44% 43
2013
Q2
$25.4M Buy
+727,257
New +$26.7M 0.5% 40

Other funds holding ABT

Baird's ABT Position: Q1 2015 in Review

Baird reduced its Abbott (ABT) stake by 23% in Q1 2015, selling an estimated $7.86M and leaving 577,979 shares worth $26.8M. The position accounts for 0.27% of the portfolio, ranked #109.

Baird first reported a position in ABT in Q2 2013 and has held it in 8 quarters since. The position peaked at $33.7M in Q4 2014. 1,474 funds tracked by Wall St. Rank hold ABT as of Q1 2015.

  • Baird held 577,979 shares of Abbott worth $26.8M as of Q1 2015.
  • Baird sold 171,149 Abbott shares in Q1 2015, an estimated $7.86M.
  • Abbott made up 0.27% of Baird's portfolio in Q1 2015, its #109 holding.
  • Baird first reported a position in Abbott in Q2 2013 and has held it in 8 quarters since.
  • Baird's Abbott position peaked at $33.7M in Q4 2014.
  • 1,474 funds tracked by Wall St. Rank held Abbott as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.